Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Cantó, E; Tintoré, M; Villar, LM; Costa, C; Nurtdinov, R; Álvarez-Cermeño, JC; Arrambide, G; Reverter, F; Deisenhammer, F; Hegen, H; Khademi, M; Olsson, T; Tumani, H; Rodríguez-Martín, E; Piehl, F; Bartos, A; Zimova, D; Kotoucova, J; Kuhle, J; Kappos, L; García-Merino, JA; Sánchez, AJ; Saiz, A; Blanco, Y; Hintzen, R; Jafari, N; Brassat, D; Lauda, F; Roesler, R; Rejdak, K; Papuc, E; de Andrés, C; Rauch, S; Khalil, M; Enzinger, C; Galimberti, D; Scarpini, E; Teunissen, C; Sánchez, A; Rovira, A; Montalban, X; Comabella, M.
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Brain. 2015; 138(Pt 4):918-931 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Enzinger Christian
Khalil Michael
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
Chitinase 3-like 1 (CHI3L1) has been proposed as a biomarker associated with the conversion to clinically definite multiple sclerosis in patients with clinically isolated syndromes, based on the finding of increased cerebrospinal fluid CHI3L1 levels in clinically isolated syndrome patients who later converted to multiple sclerosis compared to those who remained as clinically isolated syndrome. Here, we aimed to validate CHI3L1 as a prognostic biomarker in a large cohort of patients with clinically isolated syndrome. This is a longitudinal cohort study of clinically isolated syndrome patients with clinical, magnetic resonance imaging, and cerebrospinal fluid data prospectively acquired. A total of 813 cerebrospinal fluid samples from patients with clinically isolated syndrome were recruited from 15 European multiple sclerosis centres. Cerebrospinal fluid CHI3L1 levels were measured by enzyme-linked immunosorbent assay. Multivariable Cox regression models were used to investigate the association between cerebrospinal fluid CHI3L1 levels and time to conversion to multiple sclerosis and time to reach Expanded Disability Status Scale 3.0. CHI3L1 levels were higher in patients who converted to clinically definite multiple sclerosis compared to patients who continued as clinically isolated syndrome (P = 8.1 × 10(-11)). In the Cox regression analysis, CHI3L1 levels were a risk factor for conversion to multiple sclerosis (hazard ratio = 1.7; P = 1.1 × 10(-5) using Poser criteria; hazard ratio = 1.6; P = 3.7 × 10(-6) for McDonald criteria) independent of other covariates such as brain magnetic resonance imaging abnormalities and presence of cerebrospinal fluid oligoclonal bands, and were the only significant independent risk factor associated with the development of disability (hazard ratio = 3.8; P = 2.5 × 10(-8)). High CHI3L1 levels were associated with shorter time to multiple sclerosis (P = 3.2 × 10(-9) using Poser criteria; P = 5.6 × 10(-11) for McDonald criteria) and more rapid development of disability (P = 1.8 × 10(-10)). These findings validate cerebrospinal fluid CHI3L1 as a biomarker associated with the conversion to multiple sclerosis and development of disability and reinforce the prognostic role of CHI3L1 in patients with clinically isolated syndrome. We propose that determining cerebrospinal fluid chitinase 3-like 1 levels at the time of a clinically isolated syndrome event will help identify those patients with worse disease prognosis. © The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Find related publications in this database (using NLM MeSH Indexing)
Adipokines - biosynthesis
Adipokines - cerebrospinal fluid
Adult -
Aged -
Aged, 80 and over -
Biomarkers - cerebrospinal fluid
Brain - metabolism
Brain - pathology
Chitinase-3-Like Protein 1 -
Demyelinating Diseases - cerebrospinal fluid
Demyelinating Diseases - diagnosis
Female -
Follow-Up Studies -
Humans -
Lectins - biosynthesis
Lectins - cerebrospinal fluid
Male -
Middle Aged -
Prognosis -
Young Adult -

Find related publications in this database (Keywords)
clinically isolated syndrome
biomarker
multiple sclerosis
disability progression
© Meduni Graz Impressum